Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Redondo

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Pediatric Diabetes|August 13, 2021
Exome sequencing in children with clinically suspected maturity-onset diabetes of the youngMustafa Tosur, Claudia Soler-Alfonso, Katie M Chan, et al.
Diabetes Care|March 21, 2022
Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic YouthRichard A Oram, Seth A Sharp, Catherine Pihoker, et al.
Diabetologia|May 10, 2025
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matterLauric A Ferrat, Erin L Templeman, Andrea K Steck, et al.
Pediatric Diabetes|April 30, 2025
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 DiabetesTaylor M Triolo, Laura M Jacobsen, David Cuthbertson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2020
Racial-Ethnic Inequity in Young Adults With Type 1 DiabetesShivani Agarwal, Lauren G Kanapka, Jennifer K Raymond, et al.
Journal of Autoimmunity|October 26, 2005
Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetesTheresa A Aly, Akane Ide, Kurt Humphrey, et al.
Diabetes Care|August 7, 2021
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet CohortsMichael G Voss, David D Cuthbertson, Mario M Cleves, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Diabetes Care|July 22, 2025
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention StudyErin L Templeman, Lauric A Ferrat, Nicholas Thomas, et al.
BMC Medicine|July 21, 2025
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studiesErin L Templeman, Lauric A Ferrat, Hemang M Parikh, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Pediatric Diabetes|August 13, 2021
Exome sequencing in children with clinically suspected maturity-onset diabetes of the youngMustafa Tosur, Claudia Soler-Alfonso, Katie M Chan, et al.
Diabetes Care|March 21, 2022
Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic YouthRichard A Oram, Seth A Sharp, Catherine Pihoker, et al.
Diabetologia|May 10, 2025
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matterLauric A Ferrat, Erin L Templeman, Andrea K Steck, et al.
Pediatric Diabetes|April 30, 2025
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 DiabetesTaylor M Triolo, Laura M Jacobsen, David Cuthbertson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2020
Racial-Ethnic Inequity in Young Adults With Type 1 DiabetesShivani Agarwal, Lauren G Kanapka, Jennifer K Raymond, et al.
Journal of Autoimmunity|October 26, 2005
Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetesTheresa A Aly, Akane Ide, Kurt Humphrey, et al.
Diabetes Care|August 7, 2021
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet CohortsMichael G Voss, David D Cuthbertson, Mario M Cleves, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Diabetes Care|July 22, 2025
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention StudyErin L Templeman, Lauric A Ferrat, Nicholas Thomas, et al.
BMC Medicine|July 21, 2025
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studiesErin L Templeman, Lauric A Ferrat, Hemang M Parikh, et al.
Pageof 26